38 results match your criteria: "M Joshi Eye Institute[Affiliation]"
Indian J Ophthalmol
January 2024
Department of Vitreoretina, M M Joshi Eye Institute, Hubballi, Karnataka, India.
Purpose: To analyze the surgical outcomes of petalloid multilayered inverted internal limiting flap using perfluorocarbon liquid (PFCL) in extra-large macular holes (MHs) (minimum linear diameter >550 µm and basal diameter [BD] >1000 µm).
Methods: This was a prospective interventional series of 103 eyes of 99 patients with extra-large MHs which were treated with 25-gauge pars plana vitrectomy, petalloid multilayered inverted internal limiting membrane flaps under PFCL and 15% perfluoropropane (C3F8) gas tamponade. Intraoperative optical coherence tomography (i-OCT) was used to confirm correct positioning of flaps.
Indian J Ophthalmol
October 2023
Department of Vitreoretina, M Joshi Eye Institute, Hubli, Karnataka, India.
Purpose: To assess short-term efficacy of a single injection of brolucizumab in neovascular AMD.
Methods: This was a multicenter, retrospective chart review of 25 eyes of 25 patients who received a single injection of brolucizumab. Visual acuity (VA) and optical coherence tomography (OCT) features such as central subfield thickness (CSFT), subretinal fluid (SRF), intraretinal fluid, and pigment epithelial detachment (PED) were recorded at baseline, first month, and third month.
Indian J Ophthalmol
March 2023
Director, Research and Community Service, M.M. Joshi Eye Institute, Hosur Road, Hubli, Karnataka, India.
Indian J Ophthalmol
March 2023
M.M. Joshi Eye Institute, Hosur Road, Hubli, Karnataka, India.
Eye (Lond)
October 2023
Pink city eye and retina center, Jaipur, Rajasthan, India.
Introduction: The incidence of post vitrectomy endophthalmitis (PVE) is reported to be between 0.02 and 0.84%.
View Article and Find Full Text PDFIndian J Ophthalmol
August 2022
Department of Vitreoretina, M. M. Joshi Eye Institute, Hubli, Karnataka, India.
Indian J Ophthalmol
May 2022
Optometrist, Trenetralaya, Kolkata, India.
Purpose: : To determine the prevalence of diabetic retinopathy (DR) and its risk factors among diabetic patients in the states of Madhya Pradesh (MP) and Chhattisgarh (CG).
Methods: : Diabetic patients were screened in the treating diabetologist/physician's clinic by a team that included an ophthalmologist, an optometrist, and a counselor. Demographic details, diabetic control, compliance to eye checkup, awareness regarding diabetic blindness, and visual acuity were recorded using a questionnaire.
Ocul Immunol Inflamm
August 2023
Department of Vitreoretina, M. M. Joshi Eye Institute, Hubballi, India.
Purpose: To study clinical and imaging features of presumed post-COVID infection retinitis.
Method: Retrospective case series of patients presenting with retinitis lesions with evidence of recent COVID infection. Retinal findings and optical coherence tomography (OCT) features were studied at baseline and follow-ups.
Ophthalmol Retina
January 2022
M M Joshi Eye Institute, Hubballi, Karnataka, India.
JAMA Oncol
March 2022
Institute for Health Metrics and Evaluation, University of Washington, Seattle.
Indian J Ophthalmol
January 2022
Department of Vitreoretina, M M Joshi Eye Institute, Hubballi, Karnataka, India.
Indian J Ophthalmol
December 2021
Department of Community and Family Medicine, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India.
Purpose: The purpose of this study was to determine the influence of outdoor activity on myopia progression.
Methods: It was a hospital-based longitudinal prospective observational study. Children between 7 and 14 years of age with a myopia of - 0.
Indian J Ophthalmol
November 2021
Senior Optometrist, Trenetralaya, Kolkata, West Bengal, India.
Purpose: The aim of this study was to determine the prevalence of diabetic retinopathy (DR) and its risk factors among diabetic patients in rural and urban West Bengal (WB).
Methods: Patients were screened in the physician's clinic by a team of ophthalmologist, optometrist and counsellor. Demographic details, diabetic control, compliance to eye checkup, awareness regarding diabetic blindness, and visual acuity were recorded using a questionnaire.
Saudi J Ophthalmol
July 2021
UPMC Eye Centre, University of Pittsburgh, USA.
Purpose: To evaluate the surgical outcomes in combined hamartoma of retina and retinal pigment epithelium (CHRRPE) using optical coherence tomography (OCT).
Methods: This was a retrospective interventional study, in which medical records of 12 eyes with CHRRPE that underwent vitrectomy and membrane peeling at three tertiary vitreoretinal institutes were reviewed. Preoperative and postoperative color fundus photographs and OCT were reviewed for each follow-up visit.
Indian J Ophthalmol
September 2021
Department of Vitreoretina, M. M. Joshi Eye Institute, Hubli, Karnataka, India.
Indian J Ophthalmol
August 2021
Department of Vitreoretina, M M Joshi Eye Institute, Hosur, Hubli, Karnataka, India.
Indian J Ophthalmol
July 2021
Department of Vitreoretina. M M Joshi Eye Institute, Hosur, Hubli, Karnataka, India.
Indian J Ophthalmol
May 2021
Department of Vitreoretina, M M Joshi Eye Institute, Hosur, Hubli, Karnataka, India.
Int J Retina Vitreous
March 2021
Clinical Development & Medical Affairs, Intas Pharmaceuticals Ltd. (Biopharma), Ahmedabad, Gujarat, India.
Background: Razumab™ (world's first biosimilar ranibizumab) is approved for several macular disorders including wet age-related macular degeneration (AMD). We evaluated the safety and efficacy of biosimilar ranibizumab in wet AMD.
Methods: This prospective, multicentre, rAnibizumab bioSimilar Safety Efficacy postmarkeTing (ASSET) study enrolled patients aged ≥ 50 years with wet AMD having best-corrected visual acuity (BCVA) between 20/40 and 20/320.
Indian J Ophthalmol
March 2021
Department of Pediatric Ophthalmology and Strabismus, M M Joshi Eye Institute, Hubli, Karnataka, India.
Purpose: The aim of this study ws to evaluate prognostic factors associated with final visual outcome in patients with congenital cataract associated with congenital rubella syndrome.
Methods: A prospective interventional analysis of preoperative systemic and ocular features of 56 eyes of 28 seropositive infants of less than 12 months presenting to us with bilateral cataract was performed. All infants were surgically treated with cataract extraction, posterior capsulorhexis, and anterior vitrectomy followed by visual rehabilitation.
Ophthalmol Retina
November 2021
UPMC Eye Center, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic address:
Purpose: To correlate structural changes of combined hamartoma of the retina and retinal pigment epithelium (CHRRPE) with patient age.
Design: Retrospective study.
Participants: Fifty eyes of 49 patients (age range, 1-74 years) with CHRRPE studied at 9 tertiary vitreoretinal institutions.
Indian J Ophthalmol
January 2021
Department of Vitreoretina, M M Joshi Eye Institute, Hosur, Hubballi, Karnataka, India.
Indian J Ophthalmol
December 2020
M. M. Joshi Eye Institute, Hubli, Karnataka, India.
Purpose: To calculate a modified percentage tissue altered (mPTA) in post laser-assisted in-situ keratomileusis (LASIK) eyes and to validate its role as an independent factor to evaluate ectasia in the Indian population.
Methods: A total of 333 consecutive eyes with normal preoperative corneal topography by combined placido and scheimpflug imaging-based topography system (SIRIUS) who underwent LASIK using a microkeratome between 2011 and 2014 at a tertiary level teaching hospital in south India, were retrospectively analyzed. Preoperatively patient's refraction, flap thickness (FT), ablation depth (AD), residual stromal bed (RSB), and thinnest corneal thickness (TCT) were recorded.
BMC Ophthalmol
October 2020
Global Patient Safety and Epidemiology (GPSE), Allergan, an AbbVie Company, Irvine, CA, USA.
Background: Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. As India has the second largest population of diabetic patients worldwide, availability of various treatment options for DME is essential. This postmarketing surveillance study was conducted to fulfill a commitment to the Regulatory Authority of India to examine the safety of dexamethasone intravitreal (DEX) implant over 1 year in Indian patients with DME receiving ≥1 DEX implant for DME-related visual impairment in clinical practice.
View Article and Find Full Text PDF